Xenon Pharmaceuticals highlighted the near completion of X-TOLE2 Phase 3 recruitment with top-line results now expected early next year, alongside continued expansion into neuropsychiatric ...

Q1 2025 Management View Ian Mortimer, President and CEO, emphasized the nearing completion of patient recruitment for the X-TOLE2 Phase 3 epilepsy study and stated, "delivering data from our X-TOLE2 ...

All four members of the Furtenbach Adventures team who prepped for their climb by hypoxic training at home and breathing Xenon gas, summited Everest today, five days after leaving the UK.

VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering ...

Nepal said Thursday it is investigating the use of Xenon gas by four British army veteran climbers during their ascent on Mount Everest, the Kathmandu Post reported. Nepal’s Department of ...

KATHMANDU, Nepal — Using xenon gas treatment and the latest technology is making climbing Mount Everest not just faster but also better for the environment, cutting down garbage and waste ...